InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.67
(
0.00%
)
US TECH 100
17,585.60
(
-0.15%
)
Dow Jones
39,056.39
(
0.44%
)
Brent Oil
83.75
(
0.22%
)
Bitcoin
61,530.00
(
0.56%
)
Post# of 6315
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

cjarmstrong

Send PM Follow Ignore
Followers 0
Posts 157
Boards Moderated 0
Alias Born 04/28/2017

cjarmstrong

Re: cjarmstrong post# 2973

Friday, 11/17/2017 12:33:57 PM

Friday, November 17, 2017 12:33:57 PM

Post# of 6315
Having said that, Elsohly developed the transmucosal patch as a successor to the suppository, so I have no idea why Nemus is developing the suppository at all. I've said it before, but I believe it's something they should abandon. A patch or even buccal pill would be significantly more lucrative.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM

Start posting your company's news
Only $200 per official company press release!